The Trump administration’s directive to make many green-card applicants wait abroad and cuts that strip immigrants of jobs, health care, and housing are creating immediate hardship for legal residents and asylum seekers — see the CNN breakdown and reporting on those whose livelihoods were lost at airports in the Globe. [P]Meanwhile, humanitarian crises from Gaza to an Ebola outbreak in Uganda and the DRC threaten displaced populations’ safety and health, underscoring how policy and epidemics combine to deepen refugee vulnerability — see IsraAID’s response here. The short version: legal routes are narrowing while acute risks for displaced people multiply, making scalable, low‑barrier interventions more urgent than ever.

A deadly new wave of overdoses is unfolding as fentanyl-meth combinations spread beyond traditional hotspots, raising urgency for harm‑reduction and treatment access (report). [P]Courts are also signaling accountability for platform design after juries hit Meta and YouTube with damages tied to youth addiction claims (legal fallout), while college and pro-athlete gambling scandals spotlight compulsive betting as a public‑health issue (Sorsby case). In short: supply-side toxicity, addictive product design, and gambling harms are converging — a triple threat for clinicians and policy makers.

A CDC-style look at changing cannabis use, school settlements with Meta over teen harm, and rising orthorexia warn that digital culture and substance shifts are reshaping youth mental health (cannabis patterns) and (social‑media settlement). [P]Cuts of 10,000 VA jobs — mostly medical — threaten veterans’ access to care just as apps and VR platforms show promise to fill gaps, highlighting both risk and opportunity for scalable digital treatments (VA cuts) and (app study). Bottom line: workforce and system strains raise demand for evidence-based digital tools and non‑pharmacologic approaches.

Researchers are mapping molecular levers for trauma — from nociceptin receptor effects to dopamine’s role as a molecular timer — suggesting novel pharmacologic targets for PTSD (nociceptin study) and (dopamine work). [P]At the same time, veterans and clinicians are turning to tech and community solutions: a Navy SEAL created an app to track mental-health changes during psychedelic therapy, and lawmakers are proposing grants to expand service‑dog programs — practical complements to emerging biology (app). Translation: biological breakthroughs plus digital and social supports could make PTSD care more personalized and scalable.